ORCHARD THERAPEUTICS PLC Comprehensive Income
ORCHARD THERAPEUTICS PLC reported Comprehensive Income of -$31.26 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-09-30 was -$31.26M.
- ORCHARD THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-06-30 was -$14.12M.
- ORCHARD THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-03-31 was -$23.07M.
- ORCHARD THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-12-31 was -$29.44M.
- ORCHARD THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$127.89M.
- ORCHARD THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$141.71M.
- ORCHARD THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$153.65M.
- ORCHARD THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$164.54M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$31.26M 10-Q · filed 2023-11-13 | -$45.38M derived: sum of 2 quarters · filed 2023-11-13 | -$68.45M 10-Q · filed 2023-11-13 | -$97.89M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | -$14.12M 10-Q · filed 2023-08-10 | -$37.19M 10-Q · filed 2023-08-10 | -$66.62M derived: sum of 3 quarters · filed 2023-08-10 | -$92.64M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | -$23.07M 10-Q · filed 2023-05-15 | -$52.51M derived: sum of 2 quarters · filed 2023-05-15 | -$78.53M derived: sum of 3 quarters · filed 2023-11-13 | -$112.00M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | -$29.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$55.46M derived: sum of 2 quarters · filed 2023-11-13 | -$88.93M derived: sum of 3 quarters · filed 2023-11-13 | -$127.89M 10-K · filed 2023-03-14 |
| 2022-09-30 | -$26.02M 10-Q · filed 2023-11-13 | -$59.49M derived: sum of 2 quarters · filed 2023-11-13 | -$98.45M 10-Q · filed 2023-11-13 | -$135.29M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$33.47M 10-Q · filed 2023-08-10 | -$72.43M 10-Q · filed 2023-08-10 | -$109.26M derived: sum of 3 quarters · filed 2023-08-10 | -$141.79M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$38.96M 10-Q · filed 2023-05-15 | -$75.80M derived: sum of 2 quarters · filed 2023-05-15 | -$108.32M derived: sum of 3 quarters · filed 2023-05-15 | -$145.31M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$36.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$69.36M derived: sum of 2 quarters · filed 2023-03-14 | -$106.35M derived: sum of 3 quarters · filed 2023-03-14 | -$141.71M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$32.52M 10-Q · filed 2022-11-14 | -$69.52M derived: sum of 2 quarters · filed 2022-11-14 | -$104.88M 10-Q · filed 2022-11-14 | -$141.55M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$36.99M 10-Q · filed 2022-08-04 | -$72.35M 10-Q · filed 2022-08-04 | -$109.03M derived: sum of 3 quarters · filed 2022-08-04 | -$134.94M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$35.36M 10-Q · filed 2022-05-12 | -$72.04M derived: sum of 2 quarters · filed 2022-05-12 | -$97.95M derived: sum of 3 quarters · filed 2022-05-12 | -$143.45M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$36.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$62.59M derived: sum of 2 quarters · filed 2022-03-30 | -$108.09M derived: sum of 3 quarters · filed 2022-03-30 | -$153.65M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$25.91M 10-Q · filed 2021-11-04 | -$71.41M derived: sum of 2 quarters · filed 2021-11-04 | -$116.97M 10-Q · filed 2021-11-04 | -$164.79M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$45.51M 10-Q · filed 2021-08-04 | -$91.06M 10-Q · filed 2021-08-04 | -$138.88M derived: sum of 3 quarters · filed 2021-08-04 | -$176.05M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | -$45.56M 10-Q · filed 2021-05-13 | -$93.37M derived: sum of 2 quarters · filed 2021-05-13 | -$130.55M derived: sum of 3 quarters · filed 2021-05-13 | -$182.41M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$47.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$84.99M derived: sum of 2 quarters · filed 2021-03-02 | -$136.85M derived: sum of 3 quarters · filed 2021-03-02 | -$164.54M 10-K · filed 2021-03-02 |
| 2019-09-30 | -$37.17M 10-Q · filed 2020-11-03 | -$89.04M derived: sum of 2 quarters · filed 2020-11-03 | -$116.72M 10-Q · filed 2020-11-03 | -$144.43M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-30 | -$51.87M 10-Q · filed 2020-08-06 | -$79.55M 10-Q · filed 2020-08-06 | -$107.26M derived: sum of 3 quarters · filed 2020-08-06 | -$141.44M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$27.69M 10-Q · filed 2020-05-07 | -$55.39M derived: sum of 2 quarters · filed 2020-05-07 | -$89.57M derived: sum of 3 quarters · filed 2020-05-07 | -$247.27M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$27.71M derived: 10-K 12 month − 6-K 9 month · filed 2020-02-27 | -$61.88M derived: sum of 2 quarters · filed 2020-02-27 | -$219.58M derived: sum of 3 quarters · filed 2020-02-27 | -$231.46M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$34.18M 6-K · filed 2019-11-07 | -$191.88M derived: sum of 2 quarters · filed 2019-11-07 | -$203.75M 6-K · filed 2019-11-07 | |
| 2018-06-30 | -$157.70M 6-K · filed 2019-08-08 | -$169.57M 6-K · filed 2019-08-08 | ||
| 2018-03-31 | -$11.88M 6-K · filed 2019-05-28 | |||
| 2017-12-31 | -$35.35M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | -$19.36M 20-F · filed 2019-03-22 |